Skip to content

Clinical trials

Phase 1/2 Colonic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Phase: Phase 1/2 Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20173
20182
20201
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Recruiting4
Completed2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd2
Beijing Biotech1
Chinese Academy of Medical Sciences1
Coherent Biopharma (Hefei) Co., Ltd.1
Essen Biotech1
First Affiliated Hospital of Chengdu Medical College1
Hoffmann-La Roche1
Shanghai Henlius Biotech1
Turning Point Therapeutics, Inc.1
Xiangya Hospital of Central South University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms12
Lung Neoplasms5
Pancreatic Neoplasms5
Esophageal Neoplasms4
Breast Neoplasms3
Rectal Neoplasms3
Stomach Neoplasms3
Adenocarcinoma2
Bronchial Neoplasms2
Carcinoma2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.